Detection of Hepatitis B Surface Antigen by Chromatographic Assay Flashcards
Viral Hepatitis
• Inflammation of the liver
• The most common liver disease
Viral hepatitis
Causative agent:
• Primary hepatitis viruses:
• Secondary hepatitis viruses:
A, B, C, D and E
EBV, CMV, and herpesvirus
Hepatitis A aka
Infectious Hepatitis
Nonenveloped, single-stranded RNA virus.
Belongs to the Hepatovirus genus of the PicoRNAviridae family.
Hepatitis A
Hepatitis A
Belongs to the_______ genus of the_______ family.
Hepatovirus genus
PicoRNAviridae family
Hepatitis A
Transmission:
Primary route:
Fecal-oral
Ingestion of contaminated food or water
Hepatitis A
Factors: (3)
• Rare cases through ______during acute infection with high viral load.
Poor hygiene, poor sanitation, and overcrowding
blood transfusion
Factors:
Poor hygiene, poor sanitation, and overcrowding.
• Rare cases through blood transfusion during acute infection with high viral load.
Hepatitis A
• Shed in feces during incubation and early acute stages but decline after symptoms appear.
Hepatitis A (HAV) antigens
Hepatitis A
Serological Tests: (2)
• ELISA
• Chemiluminescence Immunoassay
: Based on the presence of IgM antibodies to HAV.
IgM is detectable at symptom onset and declines within 6 months.
Acute Hepatitis A Diagnosis
Acute Hepatitis A Diagnosis:
: Based on the presence of_____ antibodies to HAV.
IgM is detectable at symptom onset and declines within____ months.
IgM
6 months
Hepatitis C (Non-A Non-B Hepatitis)
•_____ virus from the______
family.
RNA
Flaviviridae
• RNA virus from the Flaviviridae family.
Hepatitis C (Non-A Non-B Hepatitis)
(Non-A Non-B Hepatitis)
Hepatitis C
Hepatitis C
• Transmission: (3)
Parenteral, sexual, and perinatal routes.
85% of cases progress to chronic infection.
Hepatitis C
Hepatitis C
• Complications: (3)
Cirrhosis, hepatocellular carcinoma, and autoimmune issues.
Hepatitis C
Diagnosis:
Anti HCV - Hepatitis C antibody test
HCV RNA - Hepatitis C virus ribonucleic acid
Genotyping
Hepatitis C
Diagnosis:
: Indicates past or current infection.
: Confirms current infection and monitors treatment effectiveness.
is critical for determining treatment strategies.
Anti-HCV
HCV RNA
Genotyping
Hepatitis C (HCV) Transmission:
Exposure to contaminated blood.
Hepatitis C
• Main source:____
•_______ (before routine HCV screening in 1992).
•_______ (before 1992).
Intravenous drug use
Blood transfusion
Organ transplantation
HCV
• Other risk factors: (3)
• Occupational exposure to contaminated blood.
• Long-term hemodialysis.
• Unregulated body piercing or tattooing, particularly in correctional facilities
• Major cause of Post-transfusion Hepatitis
Hepatitis C
Hepatitis D aka
Delta Hepatitis
Hepatitis D (HDV):
• Also called ______ or _______
• Requires ________for replication and expression.
• Transmitted_______.
delta hepatitis or “viroidlike”
Hepatitis B virus (HBV)
parenterally
HDV
Requires Hepatitis B virus (HBV) for ______ and _____
replication and expression
HDV
Virus Characteristics:
Defective virus in the______ genus.
_________genome.
Contains a single structural protein,___________.
Deltavirus
Circular RNA genome
hepatitis delta antigen
Genome of HDV
Circular RNA genome
• Enveloped by HBV-derived material, including HBsAg.
HDV
HDV
• Enveloped by HBV-derived material, including______.
HBsAg
Transmission of HDV (Similar to HBV)
•_______: Via semen or vaginal secretions.
•_______: Through intravenous drug use, needlestick injuries, or transfusions.
•_______: From mother to infant.
Sexual
Bloodborne
Perinatal
HDV
Infection Types: (2)
Co-infection
Superinfection
HDV
Infection Types: (2)
• Co-infection:
• Superinfection:
HDV and HBV are transmitted simultaneously.
HDV infects individuals already chronically infected with HBV.
Nonenveloped, single-stranded RNA virus in the Hepevirus genus (HepEviridae family).
Major global cause of hepatitis, with 20 million infections and 3.3 million acute cases annually.
WHO reported approximately 44,000 deaths in 2015.
Hepatitis E Virus (HEV)
Hepatitis E Virus (HEV)
• Nonenveloped, single-stranded RNA virus in the ________ genus of ______ family
• Major global cause of hepatitis, with______ infections and ______acute cases annually.
• WHO reported approximately_______ deaths in 2015.
Hepevirus genus (HepEviridae family).
20 million; 3.3 million
44,000
HEV
Transmission: (2)
Fecal-oral route
Person-to-person
HEV
Transmission: (2)
Primary route:
Person-to-person transmission:
Fecal-oral (similar to HAV).
Rare. Fatal in pregnant.
Detected in blood supplies in several countries.
Can be transmitted via blood transfusions.
HEV
• complex deoxyribonucleic acid
(DNA) virus
• family HepaDNAviridae
Hepatitis B Virus
Hepatitis B Virus
• complex_______ virus
• family_______
deoxyribonucleic acid (DNA) virus
HepaDNAviridae
Hepatitis B Virus
• Viral proteins of importance include the following:
envelope protein-HBsAg
structural nucleocapsid core protein-hepatitis B core antigen (HBcAg)
soluble nucleocapsid protein-hepatitis
B e antigen (HBeAg)
Hepatitis B Infection aka
Serum Hepatitis
Hepatitis B Infection (Serum Hepatitis)
Causative agent:
Hepatitis B virus
Birth to an infected pregnant person
Contact with infected body fluids like blood, saliva, vaginal fluids and semen
Blood transfusion
Hepatitis B Infection (Serum Hepatitis)
Hepatitis B Infection (Serum Hepatitis)
Signs and symptoms (6)
yellowing of the skin and eyes (jaundice)
dark urine
feeling very tired
nausea
vomiting
pain in the abdomen
HBV
Prevention:
vaccine
HBV
Lab test:
____________- screening
________
___________- confirmatory
Immunochromatographic test
RIA
ELISA
initial detectable marker found in serum during the incubation period of HBV
infection
Hepatitis B surface Antigen (HBsAg)
Hepatitis B surface Antigen (HBsAg)
detectable _______ to______before clinical symptoms and_______ after infection
present for_______
2 weeks to 2 months ; 2 weeks
2 to 3 months
+ indicates active HBV infection, acute or chronic
Hepatitis B surface Antigen (HBsAg)
Active viral replication
monitor a patient’s response to HBV therapy
Hepatitis B related Antigen (HBeAg)
Hepatitis B related Antigen (HBeAg)
indicates…
Active viral replication
monitor a patient’s response to HBV therapy
Hepatitis B core Antibody (Anti-HBc)
______: recent hepatitis B infection
______: Lifelong Marker
______: detected by liver biopsy
IgM
IgG
HBcAg
identification of a person recently recovered from an HBV infection who may still be infectious
Reliable marker during window period
Hepatitis B core Antibody (Anti-HBc)
Anti-Hbe
indicates…
+ convalescent phase
Anti-HBs
indicates…
marker of recovery and immunity
HBsAg (+)
Early (asymptomatic)
Acute or chronic
Anti-HIBs (+)
Acute or chronic
Long after infection
Immunized with HBsAg
Anti-HBc (+)
Acute or chronic
Low-level carrier
Immediate recovery
Long after infection
Anti-HBc (IgM) - (+)
Acute or Chronic
Immediate recovery